High adherence to HIV prophylaxis may raise efficacy for couples where one partner has HIV

The study, which was led by Jessica Haberer, from Harvard Medical School, Boston, United States, included 1,147 HIV-uninfected participants who were enrolled in three Ugandan sites of the Partners PrEP Study- a randomized controlled trial to determine efficacy and safety of PrEP.

http://www.sciencedaily.com/releases/2013/09/130910205426.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fstd+%28ScienceDaily%3A+Health+%26+Medicine+News+--+STD%29